...

the innovative cation exchanger offers

by user

on
Category: Documents
18

views

Report

Comments

Transcript

the innovative cation exchanger offers
C
strong mixed-mode polymer-based
cation exchanger for basic analytes
強カチオン交換ー逆相ミックス
モード・ポリスチレンージビニ
ルベンゼン固相抽出カラム
. . . the innovative cation exchanger o!ers:
HR-XC
mixed-mode
SPE phase with distinct cation exchange and RP properties
CHROMABOND®
HR-XC:塩基性試料用・強カチオン交換ー逆相ミックスモードポリマー充填剤
your benefit ! excellent enrichment of basic analytes
◆ カチオン交換と逆相モードによる保持機構:塩基性試料の選択的な濃縮・抽出が可能です。
modern, spherical support polymer with optimised pore structure and large surface
◆ 最適化された細孔構造、高い表面積
サンプルの負荷容量が大きく、通液・溶出特性に優れています。
your benefit ! good reproducibility, reliable and cost-e!cient analyses
溶媒使用量が少なく、前処理コストを削減します。
more aggressive washing procedures for matrix removal possible
◆ イオン交換モードによる保持:通常の前処理よりもクリーンアップ能力が改善
強力な溶媒洗浄が可能、妨害成分の除去に有効
your benefit ! cleaner samples and protection of your HPLC and GC instrumentation
◆ 複雑なマトリックスの前処理に有効:共存成分、妨害成分を除き、高感度分析に有利です。
quantification of analytes from heavily contaminated samples
CHROMABOND® HR-Xと組み合わせ、塩基性試料の前処理に最適です。
your benefit ! lower limits of detection also for critical matrices
… the perfect fit for basic analytes in combination with CHROMABOND® HR-X
similar phases: Oasis® MCX, StrataTM X-C, StyreScreen® DBX
(trademarks of Waters, Phenomenex® and UCT)
www.mn-net.com
strong cation exchanger
HR・ 強カチオン交換ー逆相ミックスモード・ポリスチレンージビニルベンゼン充填剤
strong benzenesulphonic acid cation exchanger
exchange capacitymeq
1.0/gmeq/g
・ イオン交換容量:1.0
recommended application:
・ 特に塩基性試料の選択的抽出に最適
values due to an optimised production process
・ アプリケーション:
spherical particles, particle size 85 "m; pore size 65-75 Å
very尿中、血清中、血漿中の塩基性薬物の濃縮抽出 食品中防かび剤、アミン類の抽出等
large specific surface 800 m2/g; pore volume 1.4 cm3/g
fungicides from food
basic active ingredients from
・ 使用pH範囲:1-14
base material polystyrene-divinylbenzene copolymer
strongly matrix-contaminated sam・ 球状85um,
細孔径65-75Å,
表面積:800
m2/g,
細孔容量:1.4
cm3/g
負荷容量:300 mg/g
(水中のカフェインの場合)
pH stability
1-14; RP capacity
300
mg/g
(ca!eine in
water)
ples
like e.g. urine, plasma, serum
・ 新規製造法によりバックグランドが低く、再現性に優れた高純度素材
high-purity material, highest reproducibility and lowest blank
basic analytes like e.g. amines
Solid phase extraction
outstanding recovery rates especially for the enrichment of basic
analytes
Standard
protocol to start your
CHROMABOND® HR-XC
method
development with
標準的な前処理手順
CHROMABOND® HR- C
MN Appl. No. 304790
Column type: CHROMABOND® HR-XC
3 ml/200 mg, Cat. No. 730952
1. Sample pretreatment: if necessary adjust pH value
1.試料溶液の前処理:必要によりpHを調整する
2. Column conditioning: 5 ml MeOH
2.コンディショニング: 5 ml メタノール
3. Equilibration: 5 ml water
3.平衡化:5 ml 水
4. Sampe application: slowly apply sample
4.試料負荷
5. Washing: a) 2 ml 0.1 N HCl in water
5.洗浄:
a) 2 mL 0.1N HCl
b) 2 ml MeOH (if necessary, further washing steps)
b) 2 ml メタノール (必要に応じて更に洗浄)
6. Elution: after drying 5 ml MeOH / 5% NH3
6.溶出: 吸引乾燥後、5 mL, 5% NH3 含有メタノールで回収
7. Further analysis: if necessary, evaporate and
redissolve in a suitable solvent; HPLC or GC
Fractionation
of acidic, neutral and
血清中酸性、中性、塩基性薬物の一斉抽出
basic analytes from serum
MN Appl. No. 304780
Column type: CHROMABOND® HR-XC
3 ml/200 mg, Cat. No. 730952
Sample:
1 ml spiked2%リン酸200uLを加えて酸性に調整済み
matrix, acidified with 200 "l 2% H3PO4
試料:1 mLスパイク血清
コンディショニング: 5 ml メタノール
Column
conditioning:
5 ml MeOH, 5 ml water
平衡化:5 ml 水
試料負荷:スパイク血清1.2mlをそのまま負荷
Sample
application: 1.2 ml spiked serum
洗浄:2 mL 0.1N HCl
溶出:
Washing:
2 ml 0.1 N HCl in water
a) 2.5 mL メタノール (フラクションA:中性、酸性薬物)
Elution:
2.5
MeOH (fraction A: neutral and acidic analytes)
b) 5 mL , a)
10%
NH3ml
含有メタノール (フラクションB:塩基性薬物)
b) 5 ml MeOH / 10% NH3 (fraction B: basic analytes)
3.500
mAU
3.000
100
Sample from serum
without SPE
2.000
80
Recovery rate [%]:
Fraction A: acidic
Fraction B: basic analytes
and neutral analytes
Compound HR-XC Compound HR-XC Oasis® MCX StrataTM X-C
Doxepin
101
68
82
108
Suprofen
85
Imipramine
95
71
85
Naproxen
73
Tolmetin
Amitriptyline
94
72
78
Phenobarbital 108
Trimipramine 92
70
81
Indomethacin 33
further analysis: HPLC on NUCLEODUR® C18
Hexobarbital 80
or C8 Gravity, see MN Appl. No. 122230 + 118520
1.000
60
after SPE with HR-XC
0
40
Peaks:
1. Doxepin
2. Imipramine
3. Amitriptyline
4. Trimipramine
20
after SPE
with HR-XC
0
0
5
10
15
min
Ordering information
Volume
Adsorbent weight
Pack of
3 ml
6 ml
200 mg
730952
500 mg
730953
730955
30
30
CHROMAFIX® HR-XC cartridges
Size/Weight Ø
S/155 mg
M/240 mg
L/500 mg
731755
731756
731757
50
CHROMABOND® HR-XC adsorbent
730664
www.mn-net.com
MACHEREY-NAGEL GmbH & Co. KG · Neumann-Neander-Str. 6-8 · D-52355 Düren · Germany
URL:http://www.chemco.jp/
Germany
Switzerland:
France:
and international:
MACHEREY-NAGEL
AG
MACHEREY-NAGEL EURL
e-mail: [email protected]
Tel.: +49 (0) 24 21 96 90
Tel.: +41 (0) 62 388 55 00
Tel.: +33 (0) 3 88 68 22 68
Fax: +49 (0) 24 21 96 91 99
Fax: +41 (0) 62 388 55 05
Fax: +33 (0) 3 88 51 76 88
e-mail:[email protected]
e-mail:[email protected]
e-mail:[email protected]
!"#$%%&'30-0016%!"()*+,2-8-14(-./0)
TEL 06-6375-0395(1), FAX 06-6372-0533
23456%&708-0074%2389*:;2-19-17(:;<=>?@)
TEL 03-3444-4201(1), FAX 03-3444-4238
USA:
MACHEREY-NAGEL Inc.
Tel.: +1 484 821 0984
Fax: +1 484 821 1272
e-mail:[email protected]
100 g
SPE HR-XC e1/3/5/4.08 PD
KATEN200068 / Printed in Germany
CHROMABOND® HR-XC polypropylene columns
Fly UP